UK Life Sciences Must Move From Innovation Pilots to National Adoption
From the article
The UK is not short of innovation. The challenge is building the national systems, funding routes and procurement models needed to turn promising pilots into practical impact for patients.
Continue reading on politicsuk.comYou might also wanna read
Why single-payer health systems may struggle with cutting-edge biomedical innovation
The article argues that single-payer government-run health care systems are adequate for routine, established medical treatments but perform
marginalrevolution.com·2h ago
2025 Highlights: Accelerating Innovation into Healthcare
bartslifesciences.org·6mo ago
How to advance revolutionary science: high turnover, high risk and a licence to fail
Nature Communications·1d ago
How to advance revolutionary science: high turnover, high risk and a licence to fail
nature.com·1d ago
China's biotech rise: A case study in multiple myeloma drug development
This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc
writingruxandrabio.com·16d ago
China's healthcare sector faces higher barriers than EVs in global innovation push
China's healthcare sector is emerging as a potential new frontier for innovation and globalization, following the success of its electric ve
weforum.org·17d agoUK mid-market AI pilots stall despite high confidence
IT Brief UK·8h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.